Simposi
From Psychological Stress To Neurodegeneration: Novel Pharmacological Targets And Neuroprotective Approaches
27 ottobre 2017 / 8.30-10.30
125 |
Trascriptome Meta Analysis to Identify Novel Pharmacological Targets in Parkinson’s Disease Andrea Tarozzi (Rimini) |
126 |
Update on treatment of Parkinson’s Disease Manuela Contin (Bologna) e Pietro Cortelli (Bologna) |
127 |
Targeting GluN2A-containing N-Methyl-d-aspartate receptors (NMDA) in Parkinson’s Disease and Levodopa-induced dyskinesia (L-DOPA) Fabrizio Gardoni (Milan) |
128 |
Evaluation of the possible therapeutic potential of palmitoylethanolamide in a transgenic animal model of Alzheimer’s disease: focus on neuroinflammation and synaptic dysfunction Luca Nicola Ferraro (Ferrara) |
129 |
A preclinical study on the nootropic effects of ferulic acid through the heme oxygenase/carbon monoxide system Cesare Mancuso (Rome) |